A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The list of benefits for Novo Nordisk's semaglutide keeps getting longer ... City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS), compared to an 8.7 reduction with placebo.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

RAs, might offer new ways to reduce dementia risk. Discover the latest research and what it means for Alzheimer's treatment.

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

An NBA regular season marked by shocking trades and stunning dismissals of coaches whose teams were in the playoff hunt came down to the final day for six Western Conference teams to learn, and ...

FDA and Novo Nordisk warn about counterfeit Ozempic in the U.S. with fake serial numbers, posing risks due to unknown ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help ... enrolled individuals with higher body mass index (BMI) scores – at least 23 and most above 30, putting them into ...

Background: Obesity is a complex, chronic, stigmatized disease whereby abnormal or excess body fat may impair health or ...